Gene · 8932
Papers2,613
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,613
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Loss of MBD2 is associated with tumor growth in small intestinal neuroendocrine tumors. | Endocr Connect | 2025 | 40937762 | PubTator, text mining | PubMed |
| KCC-07, MBD2 Inhibitor, Expands the Therapeutic Window of DNA Damage Inducing Reagents in Neural Tumor Cells. | Exp Neurobiol | 2025 | 40925882 | PubTator, text mining | PubMed |
| Metabolic dysregulation in pulmonary fibrosis: insights into amino acid contributions and therapeutic potential. | Cell Death Discov | 2025 | 40858556 | PubTator, text mining | PubMed |
| Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy. | Diabetes Metab Res Rev | 2025 | 40831067 | PubTator, text mining | PubMed |
| Deoxynivalenol induces global DNA hypomethylation by modulating the expression of miR-29b and DNA methylation regulators in HepG2 cells. | Food Chem Toxicol | 2025 | 40749799 | PubTator, text mining | PubMed |
| The role of epigenetics in pulmonary fibrosis: recent advances in mechanistic insights and therapeutic implications. | Front Mol Biosci | 2025 | 40746422 | PubTator, text mining | PubMed |
| M6A RNA modification: focusing on non-small cell lung cancer progression, therapeutic strategies and challenges. | Front Oncol | 2025 | 40740874 | PubTator, text mining | PubMed |
| Removal of promoter CpG methylation by epigenome editing reverses HBG silencing. | Nat Commun | 2025 | 40715076 | PubTator, text mining | PubMed |
| Methyl-CpG-binding domain as a protein interaction partner in promoter regulation and neurodevelopment through evolutionary expanded entanglement. | Am J Physiol Cell Physiol | 2025 | 40712661 | PubTator, text mining | PubMed |
| Development and validation of an MBD3/UHRF1 methylation-regulator-based prognostic model for pancreatic cancer survival. | Transl Cancer Res | 2025 | 40687248 | PubTator, text mining | PubMed |
| Knockdown of MBD2 Attenuates LPS-Stimulated Inflammation and Apoptosis in WI-38 Cells Through the STAT-3 Pathway. | Arch Immunol Ther Exp (Warsz) | 2025 | 40682860 | PubTator, text mining | PubMed |
| Exploring the bistable equilibrium of methylated CpG DNA recognition by the MBD2 protein. | bioRxiv | 2025 | 40631181 | PubTator, text mining | PubMed |
| Fumonisin B1 induces global DNA hypermethylation in human glioblastoma U87MG cells. | Epigenetics | 2025 | 40566980 | PubTator, text mining | PubMed |
| The role of MBD2 in immune cell development, function, and autoimmune diseases. | Cell Death Discov | 2025 | 40533455 | PubTator, text mining | PubMed |
| Statement of Retraction: KDM6B Histone Demethylase is an Epigenetic Regulator of Estrogen Receptor β Expression in Human Pleural Mesothelioma. | Epigenomics | 2025 | 40470605 | PubTator, text mining | PubMed |
| Characterization and differential expression of DNA methyltransferase and demethylase genes in response to abiotic stress in Isodon rubescens. | BMC Plant Biol | 2025 | 40468179 | PubTator, text mining | PubMed |
| Comprehensive Analysis of RNA Modifications Related Genes in the Diagnosis and Subtype Classification of Dilated Cardiomyopathy. | J Inflamm Res | 2025 | 40395552 | PubTator, text mining | PubMed |
| Comparative proteomics and structure-based approach to unravel the therapeutic drug target of Theileria species. | J Genet Eng Biotechnol | 2025 | 40390487 | PubTator, text mining | PubMed |
| The m6A demethylase FTO controls Th1 differentiation and immunity against infections. | Mol Immunol | 2025 | 40378511 | PubTator, text mining | PubMed |
| Uncovering the Molecular Interactions Underlying MBD2 and MBD3 Phase Separation. | J Phys Chem B | 2025 | 40350613 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8932/papers?page=4